4D-310
Sponsors
4D Molecular Therapeutics
Conditions
Fabry Disease
Phase 1
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease
Active, not recruitingNCT04519749
Start: 2020-09-01End: 2030-06-30Target: 18Updated: 2024-04-08
4D-310 in Adults With Fabry Disease and Cardiac Involvement
RecruitingNCT05629559
Start: 2022-10-16End: 2030-06-30Target: 18Updated: 2025-02-21